Abstract

Understandably, conventional therapeutic strategies have focused on controlling primary tumors. We ask whether the cost of such strategies is actually an increased likelihood of metastatic relapse.

Original languageEnglish
Pages (from-to)643-647
Number of pages5
JournalCancer discovery
Volume14
Issue number4
DOIs
StatePublished - Apr 1 2024

Fingerprint

Dive into the research topics of 'Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME'. Together they form a unique fingerprint.

Cite this